- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Low P/E Dividend Stocks
Hong Kong Pharmaceuticals & Biotech Low P/E Dividend Stocks
Results
6
6 companies
Essex Bio-Technology
Market Cap: HK$1.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.94
7D
7.7%
1Y
-35.9%
Tong Ren Tang Technologies
Market Cap: HK$4.1b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.34
7D
6.7%
1Y
-32.1%
China Shineway Pharmaceutical Group
Market Cap: HK$5.6b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.54
7D
1.5%
1Y
-8.9%
Jacobson Pharma
Market Cap: HK$2.1b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.05
7D
5.0%
1Y
-37.5%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.5b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.00
7D
1.0%
1Y
-19.4%
Pak Fah Yeow International
Market Cap: HK$754.2m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.49
7D
3.8%
1Y
-6.0%